Minimally Invasive Surgical Instrument Market - Product (Handheld Instruments, Guiding Devices, Electrosurgical Devices, Auxiliary Devices), Surgery Type (Cardiothoracic, Gastrointestinal, Orthopedic, Gynecological), End-use & Forecast, 2024-2032

Minimally Invasive Surgical Instrument Market - Product (Handheld Instruments, Guiding Devices, Electrosurgical Devices, Auxiliary Devices), Surgery Type (Cardiothoracic, Gastrointestinal, Orthopedic, Gynecological), End-use & Forecast, 2024-2032

Minimally Invasive Surgical Instrument Market Size

Minimally Invasive Surgical Instrument Market was valued at over USD 25.7 billion in 2023 and is anticipated to grow at a CAGR of over 8.1% between 2024 & 2032. This robust market growth can be attributed to various factors, including the increasing prevalence of chronic diseases, continual technological advancements, growing aging population, and rise in surgical volumes among others. Additionally, surging demand for cosmetic and aesthetic procedures, and increasing investments in healthcare infrastructure are also supporting the market growth.
 

Moreover, cardiovascular disorders, diabetes, and obesity are on the rise globally. Many of these diseases demand surgical intervention, and minimally invasive methods are often chosen as they have a relatively lower impact on the patient's health. The growing incidence of chronic diseases is a major factor for the adoption of MIS instruments. For instance, according to the Centers for Disease Control and Prevention, in 2022, 38.4 million Americans, or 11.6% of the U.S. population had diabetes. Furthermore, continuous advances in materials science and instrument design enable to create more durable, flexible, and efficient minimally invasive surgical devices. Instruments with enhanced ergonomics and materials, such as lightweight alloys and advanced polymers, increase surgical procedure usability and performance.
 

Minimally invasive surgical instruments are specialized tools designed for performing surgical procedures through small incisions or natural body openings. These instruments enable surgeons to access and visualize internal organs or structures with minimal disruption to surrounding tissues.
 

COVID-19 Impact

The COVID-19 pandemic had a negative impact on the minimally invasive surgical instrument market. This has culminated in the suspension of routine (or elective) procedures in order to shift healthcare personnel and resources to combat the pandemic. Thus, during the pandemic, the popularity and use of minimally invasive surgery (MIS) has decreased. However, as the number of cases affected through virus declined, the industry evolved towards pre-pandemic levels and witness a surge in the number of procedural volumes for minimally invasive surgeries performed by the surgeons.
 

Minimally Invasive Surgical Instrument Market Trends

Surging demand for integrated artificial intelligence (AI) in healthcare and MIS procedures, rise in need for smart technologies into surgical instruments, are among the key variables boosting the technological advancement in industry. Moreover, factors such as growing trend toward the use of disposable and single-use instruments collectively contribute to the evolving landscape of the minimally invasive surgical instrument industry.
 

• The use of surgical robots in minimally invasive surgeries is becoming more prevalent since last few decades as  it offers improved accuracy, dexterity, and visualisation. Surgeons are more frequently employing robotic platforms for complex surgeries as they are more sophisticated. The trend is outlined by continual advancements in robotic technology, that increases the scope of minimally invasive procedures across multiple specialties.
   
• Additionally, materials and manufacturing technology advancements have resulted in the development of smaller and more accurate instruments. Miniaturised devices are highly beneficial in microsurgery and other operations that need precise manoeuvring. Miniaturisation increases the adaptability and capability of MIS equipment, enabling for more delicate and specialised treatments.
   

Minimally Invasive Surgical Instrument Market Analysis

Minimally invasive surgical instrument industry by product is segmented into handheld instruments, inflation devices, cutter instruments, guiding devices, electrosurgical devices, auxiliary devices, and monitoring & visualization devices. The handheld instruments segment is further divided into graspers, retractors/elevators, suturing instruments, dilators, and other handheld instruments. The handheld instruments segment accounted for majority revenue share and was valued at around USD 6.1 billion revenue in 2023.
 

• Continuous advancements in portable device designs contribute considerably to in adoption of hand-held devices. . Improved designs are intended to improve surgeon comfort and control, enabling for more efficient and precise minimally invasive treatments as they are being designed with enhanced ergonomics, accuracy, and longevity.
   
• Moreover, handheld instruments are increasingly manufactured and customized to specific operations and surgical specializations. Tailoring devices to the specific needs of different procedures improves their efficacy. Specialised equipment that enhance performance in various minimally invasive procedures assist surgeons. These above factors are expected to drive the demand for handled instruments in the market.
   

Based on surgery type, the market is categorized into cardiothoracic surgery, gastrointestinal surgery, orthopedic surgery, gynecological surgery, cosmetic & bariatric surgery, urological surgery, and other surgery types. The cardiothoracic surgery segment dominated the market and accounted for around 24% market share in 2023.
 

• The ability to reduce harm to the chest cavity is one of the primary factors for the use of MIS devices in cardiothoracic surgery. For patients having surgeries such as coronary artery bypass grafting (CABG) or lung resections, smaller incisions result in less pain, less blood loss, and faster recovery periods. The focus on minimizing hospital stays and enhancing surgical recovery propels the use of minimally invasive treatments.
   
• Additionally, robotic-assisted surgery, which incorporates automated instruments that are operated by surgeons, has gained prominence in cardiothoracic surgeries. The robotic device enhances dexterity and enables more complex decisions in limited areas. The need for higher precision and superior outcome drives the adoption of robots in cardiothoracic surgery, particularly in operations like mitral valve replacement and robotic-assisted lung surgeries.
   

The market by end-use is categorized into hospitals & clinics, ambulatory surgical centers, and other end-users. The hospitals & clinics segment accounted for over USD 14.5 billion revenue size in 2023.
 

• Hospitals and clinics prioritize patient outcomes and satisfaction. Minimally invasive procedures, facilitated by advanced MIS instruments, often result in reduced postoperative pain, quicker recovery times, and shorter hospital stays. This aligns with the overarching goal of improving the patient experience, which, in turn, improves the efficiency and patient handling capacity of the healthcare facility.
   
• Furthermore, the ability to offer a range of minimally invasive procedures using state-of-the-art instruments provide hospitals and clinics with a competitive edge. As patients increasingly seek less invasive options, healthcare facilities that excel in providing MIS procedures can distinguish themselves in the market and attract a broader patient base.
   

North America minimally invasive surgical instrument market accounted for USD 10.2 billion revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• North America serves as a global hub for technological innovation in healthcare. Continuous advancements in robotics, imaging technologies, and smart instruments drive the adoption of MIS instruments. The region's status as a leader in medical research and development encourages healthcare facilities to invest in the latest technologies, positioning North America at the forefront of minimally invasive surgical practices.
   
• Furthermore, the high healthcare expenditure in the region provides healthcare providers with the financial capacity to invest in advanced medical technologies, including MIS instruments. Hospitals and clinics in the region are more likely to adopt state-of-the-art equipment, ensuring that patients have access to the latest and most effective minimally invasive procedures, thereby leading to the regional growth.
   

Minimally Invasive Surgical Instrument Market Share 

The minimally invasive surgical instrument industry is moderately competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including Medtronic Plc, Siemens Healthineers AG, Ethicon, Inc. (Johnson & Johnson), and GE Healthcare, among others have a notable presence in the market.

Minimally Invasive Surgical Instrument Market Companies

Some of the eminent market participants operating in the minimally invasive surgical instrument industry include

• Medtronic Plc
• Siemens Healthineer AG
• Ethicon, Inc. (Johnson & Johnson)
• GE Healthcare
• Abbott Laboratories
• Intutive Surgical, Inc.
• Nuvasive, Inc.
• Zimmer Biomet
• Stryker Corporation
• Boston Scientific Corporation
• B. Braun Melsungen AG
• CONMED Corporation
• Smith & Nephew Plc.
• Becton, Dickinson and Company
   

Minimally Invasive Surgical Instrument Industry News

• In September 2023, Stryker announced the launch of next generation of minimally invasive surgical cameras. The all-in-one instrument that offers a more vibrant image with balanced lighting, a wider color gamut and clearer delineation of fluorescence signals. This fully enhanced camera is used for advance surgeries in a variety of specialties.
   
• In August 2022, Sight Sciences, Inc. has announced the launch of SION, a surgical instrument that removes trabecular meshwork in ocular surgical operations. SION was micro-engineered and built using specialised lasers, excises tissue without cutting. As a result, when the surgeon glides the device around Schlemm's canal in a single continuous motion, SION grasps and eliminates diseased tissue.
   

Minimally invasive surgical instrument market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

Market, By Product

• Handheld instruments
• Graspers
• Retractors/elevators
• Suturing instruments
• Dilators
• Other handheld instruments 
• Inflation devices
• Cutter instruments
• Guiding devices
• Electrosurgical devices
• Auxiliary devices
• Monitoring & visualization devices

Market, By Surgery Type

• Cardiothoracic surgery
• Gastrointestinal surgery
• Orthopedic surgery
• Gynecological surgery
• Cosmetic & bariatric surgery
• Urological surgery
• Other surgery types

Market, By End-use

• Hospitals & clinics
• Ambulatory surgical centers
• Other end-users

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East & Africa